Click the images below to view
larger VEITHsymposium
Montefiore
Symposium on
Vascular and Endovascular Issues,
Techniques and Horizons ('05)
Session I: DEVELOPMENTS IN LYSIS, MECHANICAL CLOT REMOVAL AND NEW TREATMENTS FOR ARTERIAL THROMBI, DVT AND VENOUS DISEASE
| Modern Treatment Of Axillary Subclavian Vein DVT |
Bandyk, Dennis F. (M.D.) |
| A New Technique For The Treatment Of Subclavian Vein Thrombosis |
Lowe, Robert (M.D.) |
| Radiofrequency Ablation Of Varicose Veins: A Word Of Caution |
Lumsden, Alan B. (M.D., F.A.C.S.) |
| Angiojet Thrombectomy With A Distal Protection Device For Acute Limb Ischemia |
Kasirajan, Karthikeshwar (M.D.) |
| Isolated Thrombolysis For DVT Using The Trellis-8 System: Early Clinical Experience |
Arko, Frank R. (M.D.) |
| New Developments In The Endovascular Treatment Of DVT |
Silva, Jr., Michael B. (M.D.) |
| Venous Ulcers: What Really Works And What Doesn’t Based On Level I Evidence |
O'Donnell, Jr., Thomas F. (M.D.) |
| Panel Discussion |
|
Session II: NEW DEVELOPMENTS IN VARICOSE VEIN TREATMENT
| What’s The Story With Foam Sclerotherapy Of The Greater Saphenous Vein And Variceal Clusters: How To Do It, Does It Work And What Are The Complications? |
Bergan, John J. (M.D.) |
| Radiofrequency Versus Laser Versus Chemical Sclerotherapy For Endoablation Of The Saphenous Vein And When You Don’t Need To Do Stab Avulsions |
Almeida, Jose I. (M.D., F.A.C.S.) |
| New Developments In Sclerotherapy For Superficial Venous Disease: What Are The Legal Implications? |
Kabnick, Lowell S. (M.D., F.A.C.S.) |
| An International Experience Using The 980nm Laser: 7,000 Cases |
Samson, Russell H. (M.D., F.A.C.S., R.V.T.) |
| Radiofrequency Ablation For Varicose Veins: Is It Effective? A Prospective Study Of 500 Patients |
Shortell, Cynthia K. (M.D.) |
| New Technologies For The Treatment Of Varicose Veins And Venous Reflux |
Ballard, Jeffrey L. (M.D., F.A.C.S.) |
| Panel Discussion |
|
Session III: TOPICS OF INTEREST TO INTERVENTIONALISTS AND VASCULAR SURGEONS
| Possibilities In Interventional Therapy: What Are The Limits |
Abele, John E. |
| Where Is Nanotechnology And Stent Technology Going? |
Chaikof, Elliot L. (M.D., Ph.D.) |
| Value And Limitations Of Drug Eluting Stents: What Is Their Potential? |
Richter, Götz M. (M.D., Ph.D.) |
| Nanoporous Stents Can Replace Polymer Covered Stents For Drug Delivery And Avoid Some Of The Problems |
Wholey, Mark H. (M.D.) |
| Percutaneous Heart Valves Are Feasible: Progress To Date |
Leon, Martin B. (M.D.) |
| Panel Discussion |
|
| Treatment For Complex Iliac Occlusions: When Is A Bypass Indicated? |
Richter, Götz M. (M.D., Ph.D.) |
| A Simplified Approach For Crossing Total Occlusions: Forget The New Gadgets, All You Need Is A Catheter And A Wire |
Amin, Ali (M.D., F.A.C.S., F.A.C.C., R.V.T.) |
| The UK Asymptomatic Carotid Surgery Trial (ACST): What Does It Tell Us About How We Should Treat Asymptomatic Carotid Bifurcation Disease? |
Halliday, Alison (M.S., F.R.C.S.) |
| Timing Of Complications During CAS: How Can They Be Predicted? |
Cao, Piergiorgio (M.D.) |
| Endovascular Treatment Of Traumatic Vascular Injuries |
Silva, Jr., Michael B. (M.D.) |
| Panel Discussion |
|
Session IV: NEW ADJUNCTS TO IMPROVE THE RESULTS OF BYPASSES, PTA AND STENTING
| What We Have Learned About Lower Extremity Occlusive Disease From The Prevent III And Prevent IV Trials With E2F Decoy |
Conte, Michael S. (M.D.) |
| Paclitaxel Anastomotic Wrap To Improve PTFE Femoropopliteal Patency: 1 Year Results Of A Randomized Prospective Study |
Machan, Lindsay S. (M.D.) |
| Why Ultrasonic Plaque Characteristics Predict Restenosis Of SFA Lesions: What To Do About Lesions With A High Chance Of Restenosis |
Nicolaides, Andrew N. (M.S., F.R.C.S.) |
| Does Laser Treatment Have A Role In Lower Extremity Ischemia After All? |
Peeters, Patrick (M.D.) |
| Panel Discussion |
|
Session V: A NEW CRITICAL LOOK AT CAROTID STENTING (CAS) AND EMBOLIC BRAIN PROTECTION DEVICES
| Carotid Echomorphology Correlates With Embolic Risk During CAS: Should Protection Devices Be Used Selectively? |
Lin, Peter H. (M.D.) |
| Debate: In CAS, Embolic Injury Is Not The Only Risk To The Brain |
Macdonald, Sumaira (MBChB (Comm), MRCP, FRCR, PhD) |
| In CAS, Embolic Injury To The Brain Is The Main Problem |
Mathias, Klaus D. (M.D.) |
| Hemodynamic Changes During CAS Cause Half The Complications: How Can They Be Prevented? |
van Sambeek, Marc R.H.M. (M.D., Ph.D.) |
| Debate: Why The 2-Year SAPPHIRE Trial Results Are So Good For CAS Enthusiasts |
Ouriel, Kenneth (M.D., F.A.C.S., F.A.C.C.) |
| Debate: Limitations To The Value Of The SAPPHIRE Trial |
Bell, Peter R.F. (M.D., F.R.C.S., D.S.C., K.B.E.) |
| Lessons Learned To Date From CREST: Why We Need The Randomized Phase Of CREST |
Hobson II, Robert W. (M.D.) |
Panel Discussion
|
|
Session VI: UPDATE ON EVAR FOR AAAS: TRIALS, SURVEILLANCE AND MANAGEMENT OF COMPLICATIONS
| Mid-Term (Up To 3-Year) Results Of The Randomized Prospective DREAM Trial Comparing EVAR With Open AAA Repair: What Are The Implications? |
Blankensteijn, Jan D. (M.D.) |
| Do Results Of The EVAR Trials (I and II) Justify Endovascular Repair Of All AAAs In Patients With Suitable Anatomy? |
Greenhalgh, Roger M. (MD) |
| Don’t Assume AAA Growth After An Excluder Endograft Is Due To Permeability: AAA Enlargement In This Setting Is Multifactorial |
Fillinger, Mark F. (M.D.) |
| AAA Sac Wall Compliance: How To Measure It And Does It Predict Rupture Potential - Correlation With Finite Element Analysis |
Adiseshiah, Mohan (F.R.C.S.) |
| Dynamic CTA Can Assess Aneurysmal Wall Pulsatile Movement And Provide Information About Differences In Stent-Graft Performance And Effectiveness Of AAA Exclusion |
Moll, Frans L. (M.D., Ph.D.) |
| Volume Changes And Sac Pressure Correlations In Patients After EVAR |
Brunkwall, Jan S. (M.D., Ph.D.) |
| Proximal Attachment Failure Of AneuRx Endografts: How Can It Be Managed? |
Farber, Mark A. (M.D.) |
Panel Discussion
|
|
Session VII: OTHER TOPICS OF INTEREST TO INTERVENTIONAL RADIOLOGISTS AND VASCULAR SURGEONS
| Value Of Duplex Evaluation After Carotid Stenting (CAS) |
Bandyk, Dennis F. (M.D.) |
| Does Pathology Data Support The Value Of Cryoplasty And Absorbable Stents? |
Virmani, Renu (M.D.) |
| New Developments And Technical Advances In Renal Artery Stenting |
Sos, Thomas A. (M.D.) |
| BIVALARUDIN (AngioMax): Is It A Better Anticoagulant For Peripheral Arterial Interventions? |
Katzen, Barry T. (M.D.) |
| Panel Discussion |
a |
| All Metal Stents Are Not Alike In The SFA: What Is The Impact Of Stent Fractures And Will Biodegradable Stents Help? |
Biamino, Giancarlo (M.D.) |
| Update On Biodegradable (Biotronic) Metal Stents: Advantages And Limitations: Are They Better Than PTA Alone? |
Bosiers, Marc (M.D.) |
| Remote SFA Endarterectomy And Distal Aspire Stenting: Are The Multicenter Results Superior To SFA Stenting And Standard Bypasses? |
Rosenthal, David (M.D.) |
| 1 - 2 Year Results With SFA Atherectomy Using The SilverHawk Device: Why Are The Results Better Than Those Of Subintimal Angioplasty And Other Atherectomy Devices Including The Simpson Atherocath? |
Ramaiah, Venkatesh G. (M.D.) |
| Panel Discussion |
|
Session VIII: NEW DEVELOPMENTS IN ENDOVASCULAR ANEURYSM REPAIR AND TREATMENT OF COMPLICATIONS
| Are Newer 3rd Generation Stent-Grafts Safer And Better For EVAR? |
Harris, Peter L. (M.D., F.R.C.S.) |
| Update On Endovascular Repair Of Ruptured Aortic Aneurysms - Abdominal And Thoracic: The Collected World Experience |
Veith, Frank J. (M.D.) |
| Technical Details Which Make EVAR For Ruptured AAAs Easier And Safer |
Lachat, Mario (M.D.) |
| Does Suprarenal Fixation With Barbs Prevent Late Graft Migration: What Is The Effect On Renal Function? |
Malina, Martin (M.D., Ph.D.) |
| Transrenal Stent Placement In EVAR Is Not Harmful To The Kidneys: A 4-Year Controlled Study With The Powerlink Endograft |
Carpenter, Jeffrey P. (M.D.) |
| Panel Discussion |
|
| Fenestrated Aortic Endografts: What Are The Limitations And Complications? |
Verhoeven, Eric L.G. (M.D.) |
| Debate: Surgical Conversion Of Failed Endografts: When To Do It And How? |
Chaikof, Elliot L. (M.D., Ph.D.) |
| Debate: Failed Endografts After EVAR: When Should They Be Treated Endovascularly And When Open? |
Becquemin, Jean-Pierre (M.D., F.R.C.S.) |
| Debate: Reintervention For Failed EVAR: Open Conversion Is Almost Never Needed |
Riambau, Vicente (M.D., Ph.D.) |
| Type II Endoleaks After EVAR Are Not So Innocuous After All |
Panneton, Jean M. (M.D.) |
| Optimal Current Treatment For Type II Endoleaks: Is MRI Or MRA Helpful? |
Baum, Richard A. (M.D.) |
| Panel Discussion |
|
Session IX: UPDATES AND NEW CONCEPTS
| What Is Happening In Myocyte And Stem Cell Transplantation: Progress And Limitations |
Diethrich, Edward B. (M.D.) |
| IV Sodium Bicarbonate Clearly Prevents Contrast Nephropathy: Technique Of Usage Based On A Randomized Prospective Study |
Holleman, Jeremiah H. (M.D.) |
| Is Incidental (“Drive By”) Renal Arteriography Justified In Patients With PVD Or Carotid Stenosis? |
Jackson, Mark R. (M.D.) |
| Crossing Total Occlusions: Technique And New Devices |
Mewissen, Mark W. (M.D.) |
| Microleaks, Ultrafiltration, And Endotension: What To Do About Them |
Matsumura, Jon S. (M.D.) |
| Minimally Invasive Monitoring Of AAA Sac Pressure After EVAR: State Of The Art |
Ohki, Takao (M.D.) |
| Reservations About The Value Of Monitoring AAA Intrasac Pressure |
Gilling-Smith, Geoffrey L. (M.S., F.R.C.S.) |
| Panel Discussion |
|
Session X: ISVS AWARD PAPERS
| Vacuum Assisted Closure System With Direct Contact To Native Arteries And/Or Vascular Grafts To Improve The Outcome Of Perivascular Infection |
Mayer, Dieter O. (M.D.) |
| VNUS Is The Treatment Of Choice For Recurrent Long Saphenous Varicose Veins |
Braithwaite, Bruce D. (MChir, M.B.) |
| Preoperative Duplex Scanning And Intraoperative Direct Flow Correlation In Ischemic Lower Limb Revascularization |
Rossi, Fabio H. (M.D.) |
| A Comparison Of Open And Endovascular Abdominal Aortic Aneurysm Repair With Best Medical Treatment: Has The Availability Of EVAR Expanded Our Indications For Intervention And Improved Survival? |
Hynes, Niamh (M.D.) |
Panel Discussion
|
|
Session XI: FOCUS ON NEW ENDOTECHNOLOGY
| Use Of The WALLGRAFT For Traumatic Arterial Lesions |
Johnson, Matthew S. (M.D.) |
| Cutting Balloon For Peripheral Arterial And Venous Lesions: Value And Limitations |
Schutzer, Richard W. (M.D.) |
| Update On Indications And Results With Cryoplasty Based On Real World Experience |
Krajcer, Zvonimir (M.D., F.A.C.C.) |
| Cryoplasty Clinical Data: Long-Term IDE Data And Interim Below-The-Knee Study Results |
Krajcer, Zvonimir (M.D., F.A.C.C.) |
| Panel Discussion |
|
Session XII: PROGRESS IN THE TREATMENT OF THORACIC AND THORACOABDOMINAL ANEURYSMS
| Current Status Of Aortic Endografts For Type B Dissections: Advantages And Limitations |
Dake, Michael D. (M.D.) |
| Endograft Treatment Of Type B Dissections: What We Know And What We Don’t Know |
Greenberg, Roy K. (M.D.) |
| When Should Acute Type B Dissections Be Treated With Endografts And Which Graft Is Best: How Will We Know For Sure? |
Nienaber, Christoph A. (M.D.) |
| Results Of The Pivotal Trial With The Gore TAG Thoracic Graft For Thoracic Aneurysms |
Makaroun, Michel S. (M.D.) |
| Advantages And Limitations Of The Gore Thoracic Endograft For Treating Thoracic Aortic Lesions: A New Approach To Lesions Involving The Arch |
Diethrich, Edward B. (M.D.) |
| Thoracic Endografts: Unmet Needs And Emerging New Technologies |
Criado, Frank J. (M.D.) |
| Panel Discussion |
|
Session XIII MORE ON THE TREATMENT OF THORACIC AND THORACOABDOMINAL ANEURYSMS
| Endograft Repair Of Mycotic Aneurysms: Can It Work Long Term And When Should It Be The Preferred Treatment For This Entity? |
Taylor, Peter R. (M.A., MChir, F.R.C.S.) |
| Branch Technology Is Superior To Fenestrated Grafts For Short Necked And Visceral Segment Aneurysms |
Bleyn, Jacques (M.D.) |
| Will All Aortic Arch Aneurysms Be Treated Endovascularly: Are The Techniques Available? |
Chuter, Timothy A.M. (M.D.) |
| Advantages, Disadvantages And Early Results Of The Next Generation Medtronic Valiant Thoracic Endograft |
Thompson, Matthew M. (M.D.) |
| What Thoracic Aneurysms Are Best Treated By Open Surgery: Will A New Concept In Endografting (Filling Sac With Silicone Around An Endoluminal Removable Mold) Change This? |
Jacobs, Michael J. (M.D.) |
| Most Thoracic Aneurysms And TAAs Are Best Treated Open: What Does The Future Hold? |
Safi, Hazim J. (M.D.) |
| Panel Discussion |
|
Session XIV: NEW DEVELOPMENTS IN THE TREATMENT OF LOWER EXTREMITY OCCLUSIVE DISEASE
| Subintimal Angioplasty In The Treatment Of Critical Lower Extremity Ischemia: Is Above Knee Bypass Defunct? |
Meier III, George H. (M.D.) |
| Advantages To Ultrasound Guidance For Lower Extremity Angioplasty And Stenting |
Ascher, Enrico (M.D.) |
| Anastomotic Hemodynamics At The Distal End Of Lower Extremity Bypass Grafts To Improve Patency |
Harris, Peter L. (M.D., F.R.C.S.) |
| Debate: Patches And Cuffs Improve Results Of PTFE Bypasses To Tibial Arteries |
Neville, Richard F. (M.D.) |
| Panel Discussion |
|
| 2-Year Results With Heparin Bonded PTFE Grafts (Gore PROPATEN™ Grafts) For Femoropopliteal And Femorodistal Bypasses Are Encouraging |
Bosiers, Marc (M.D.) |
| Optimal Approach For Occluded Lower Extremity Bypasses With PTFE Or With Vein: The Guard Dog Study Of The Angiojet Device |
Cynamon, Jacob (M.D.) |
| Long-term (10–Year) Outcomes And Predictors Of Iliac PTA Success: Is Primary Stenting Necessary? |
Ahn, Samuel S. (M.D.) |
| Current Status Of Cryopreserved Veins As Arterial Replacement Grafts: Results Are Better Than You Think |
Farber, Alik (M.D.) |
| Minimally Invasive Distal Bypasses: Techniques And Advantages |
Lawrence, Peter F. (M.D.) |
| Panel Discussion |
|
Session XV: ADVANCES IN MEDICAL TREATMENT OF VASCULAR PATIENTS
| New Developments In Lipid And Medical Management Of Vascular Patients: What Every Vascular Surgeon Should Know |
Samson, Russell H. (M.D., F.A.C.S., R.V.T.) |
| A Simple Blood Test Can Predict Cardiac Risk In Vascular Surgery Patients: Plasma N-terminal pro-B Type Natriuretic Peptide (NT-proBNP) Accurately Predicts Cardiac Risk |
van Urk, Hero (M.D.) |
| D-dimer And C Reactive Proteins As Predictors Of Progression Of Symptomatic Peripheral Arterial Disease: D-dimer Works, CRP Does Not |
Moneta, Gregory L. (M.D.) |
| What Is Happening With Therapeutic Angiogenesis And Gene Therapy For Lower Extremity Ischemia: Will It Work? |
Kent, K. Craig (M.D.) |
| Panel Discussion |
|
Session XVI: PROGRESS IN THE TREATMENT OF AORTOILIAC AND THORACIC ANEURYSMS
| What Are The Limits Of The Gore Excluder For Aortoiliac Aneurysms And Can These Limits Be Extended? |
Matsumura, Jon S. (M.D.) |
| Reverse Bell Bottom Technique For Customized Tube Aortic And Iliac Endografts |
Cayne, Neal S. (M.D.) |
| Use Of Aortic Cuffs To Treat Thoracic Aortic Emergencies |
Brewster, David C. (M.D.) |
| Debate: CT Scanning Versus Duplex Ultrasonography For Surveillance After EVAR: CT Is Essential And Better |
AbuRahma, Ali F. (M.D.) |
| Debate: Routine CT Scanning Is Not Needed After EVAR: Duplex And Plain Films Are Often Enough |
Gilling-Smith, Geoffrey L. (M.S., F.R.C.S.) |
| Thoracic Endografts Are Better Than Fenestration Procedures For Malperfusion Due To Aortic Dissections |
Zipfel, Burkhart (M.D.) |
| Techniques For Aortic Arch Exclusion And Stent Grafting For Arch Aneurysms And Dissections |
Bergeron, Patrice F. (M.D.) |
| Endograft Treatment Of Thoracic Aneurysms: Lessons Learned During A 10-Year Experience |
Pamler, Reinhard S. (M.D.) |
| The Future Of Thoracic Surgery Will Demand A Hybrid Technology |
Kieffer, Edouard (M.D.) |
| Panel Discussion |
|
Session XVII: PROGRESS IN VASCULAR IMAGING
| Intravascular Ultrasound: Can It Now Document Plaque And Artery Morphology Or Virtual Histology |
Reid, Donald B. (M.D.) |
| Echostructure Of Carotid Plaques: Correlation With Clinical Events |
Fernandes e Fernandes, Jose (M.D., Phd, FRCS (Eng), FACS) |
| Overestimation Of Carotid Stenosis By Visual Estimation In The Era Of Carotid Stenting |
Hodgson, Kim J. (M.D.) |
| Duplex Examination Before, During And After Saphenous Vein Ablation: How To Do It And How Helpful Is It |
Almeida, Jose I. (M.D., F.A.C.S.) |
| Ultrafast CTA: How Can It Help In Planning Endovascular Procedures |
Busquet, Jacques (M.D.) |
| Skip The Angio Suite: Characterize Blunt And Penetrating Vascular Injuries With CT Alone |
Rubin, Geoffrey D. (M.D.) |
| Panel Discussion |
|
Session XVIII: PROGRESS IN DIALYSIS ACCESS TECHNIQUES AND MANAGEMENT OF COMPLICATIONS
| Economics Of An Interrupted Non-Penetrating Clip Anastomosis For Vascular Access Procedures |
Schild, A. Frederick (M.D.) |
| Balloon Angioplasty Maturation Of Arteriovenous Fistulas |
Panetta, Thomas F. (M.D.) |
| Use Of The ProCol Vascular Bioprosthesis For Hemodialysis Access |
Bernik, Thomas R. (M.D.) |
| Early Results Of A New Vascular Access System: The GRAFTcath System |
Glickman, Marc H. (M.D.) |
| Treatment Of Stenoses At The Venous Anastomoses Of Access Procedures With Stent-Grafts: Results Of A Multicenter Randomized Controlled Trial |
Haskal, Ziv J. (M.D.) |
| Molecular Therapies For Vascular Access |
Lawson, Jeffrey H. (M.D.,Ph.D.) |
| Management Of Ischemic Complications Of Access Surgery |
Davies, Alun H. (M.A., D.M., F.R.C.S.) |
Session XIX: NEW DEVELOPMENTS IN THE TREATMENT OF VENOUS DISEASE
| How To Treat Venous Ulcers Successfully Without Surgery |
Bergan, John J. (M.D.) |
| Microthrombectomy Reduces Post-Sclerotherapy Pigmentation: Technique, Timing And Results Of A Randomized Trial |
Villavicencio, J. Leonel (M.D.) |
| What’s New And Better In The Treatment Of Chronic Venous Insufficiency? |
Wakefield, Thomas W. (M.D.) |
| Progress In Artificial Venous Valves: How Close Are We To Clinical Application? |
Pavcnik, Dusan (M.D., Ph.D.) |
| Impact Of Venous Hemodynamics On Development Of Endovascular Stent-Vein Valves |
Tripathi, Ramesh K. (M.D. F.R.C.S) |
| Venous Ulcers Are Usually Due To Axial Reflux From The Thigh To The Calf: What Can Be Done About It Surgically Or Interventionally? |
Eklof, Bo G. (M.D., Ph.D.) |
| Does Radiofrequency Ablation Of The Greater Saphenous Vein Abolish Popliteal Vein Reflux? |
Hingorani, Anil P. (M.D.) |
| Combined Regional Thrombolysis And Surgical Thrombectomy Is Effective Treatment For Iliofemoral DVT |
Schmidli, Jürg (M.D.) |
| Panel Discussion |
|
Session XX: NEW DEVELOPMENTS IN AORTIC ANEURYSM REPAIR AND EVAR
| Difficult Technical Challenges Of Open Infrarenal AAA Repair And How To Meet Them |
Johnston, K. Wayne (M.D., F.R.C.S.) |
| Fast Track Open AAA Repair Is Better Than EVAR: Technique And Results |
Mukherjee, Dipankar (M.D.) |
| Symptomatic Sac Enlargement And Rupture Due To Seroma After Open AAA Repair: Implications For EVAR And Endotension |
May, James (M.D., M.S., F.R.A.C.S., F.A.C.S.) |
| Could EVAR Still Be A Failed Experiment? |
Collin, Jack (M.D.) |
| 5-Year Follow-up Of 200 Patients Treated With AneuRx Grafts: Unanticipated Late Problems: Are There Predictors And What Lessons Should Be Learned |
Krajcer, Zvonimir (M.D., F.A.C.C.) |
| Material Failure Modes Of Stent-Grafts After EVAR: Will these Be Eliminated In Newer Stent-Grafts? |
Riepe, Gunnar (M.D., Ph.D.) |
| Debate: Open Repair Is Still The Gold Standard For Good Risk Patients With AAAs: Conservative Treatment Is Best For AAAs < 5.0 cm In Diameter |
Gloviczki, Peter (M.D.) |
| Debate: EVAR Should Be The Gold Standard For All AAAs With Reasonable Anatomy And Even Some 4.0 cm AAAs |
Ouriel, Kenneth (M.D., F.A.C.S., F.A.C.C.) |
| Panel Discussion |
|
Session XXI: MINIMALLY INVASIVE APPROACHES TO ARTERIAL LESIONS
| Laparoscopic Adjuncts For EVAR With Difficult Neck Morphology |
Kolvenbach, Ralf R. (M.D.) |
| Status Of Laparoscopic Robotic Aortic Surgery: Is It Beneficial Or
Just Another Gimmick? |
Wisselink, Willem (M.D.) |
| EVAR Will Be The Best Less Invasive Way To Treat AAAs |
Becquemin, Jean-Pierre (M.D., F.R.C.S.) |
| Debate: Laparoscopic Repair Will Be The Best Less Invasive Way To
Treat AAAs |
Goëau-Brissonnière, Olivier (M.D., Ph.D.) |
| Debate: Endografts Are The Way To Treat Popliteal Aneurysms And The
Results Are Durable |
Verhoeven, Eric L.G. (M.D.) |
| Debate: Open Posterior Approach To Popliteal Aneurysm Repair Prevents Sac Enlargement From Endoleak And Is Better Than Endograft
Repair And Ligation And Bypass |
Moore, Wesley S. (M.D.) |
| Advantages, Limitations And Midterm Results Of The Zenith Endograft
For EVAR: How Often Will Fenestrated Grafts Be Needed? |
Ivancev, Krassi (M.D., Ph.D.) |
| Is Thrombin Injection For Femoral Pseudoaneurysms The Best
Treatment: Results Of A Randomized Prospective Comparison And How To Avoid Problems |
Risberg, Bo (M.D., Ph.D.) |
| Panel Discussion |
|
Session XXII: NEW DEVELOPMENTS IN THE TREATMENT OF DISEASES OF THE AORTA AND ITS BRANCHES
| A New Device For Treating Type B Aortic Dissections: Early Clinical Results |
Lombardi, Joseph V. (M.D.) |
| Antegrade Retroperitoneal Aorto-Mesenteric Bypass: Technique, Indications And Results |
Criado, Enrique (M.D.) |
| Mesenteric Occlusive Disease: When Is Endo Repair Justified And When Is Open Repair Indicated? |
Kalman, Peter G. (M.D.) |
| 10 Top Technical Tips For Renal Artery Stenting |
Hodgson, Kim J. (M.D.) |
| In Situ Fenestration: A Method For Dealing With Covered Branch Arteries During Aortic Endografts |
McWilliams, Richard G. (M.D.) |
| Control And Exposure Of Upper Abdominal Vascular Injury Including The Inferior Vena Cava: State Of The Art 2005 |
Mattox, Kenneth L. (M.D.) |
| Panel Discussion |
|
Session XXIII: NEW CONCEPTS AND TREATMENTS ON THE HORIZON
| Are Autologous Tissue Engineered Blood Vessel Substitutes Feasible: Where Do We Stand With This Holy Grail? |
Sumpio, Bauer E. (M.D., Ph.D.) |
| Increased Serum Cholesterol Plus Inflammation Leads To Plaque Rupture And Death: How Can This Be Prevented? |
Callow, Allan D. (M.D., Ph.D.) |
| Dangers Of Antiplatelet Anti-Inflammatory Drug Treatment Revisited: Can These Lead To Plaque Instability And Rupture? |
DePalma, Ralph G. (M.D.) |
| Orally Administered Rapamycin Can Inhibit Myointimal Hyperplasia: Should It Be Used? |
Wilson, Samuel Eric (M.D.) |
| Panel Discussion |
|
Session XXIV: ISSUES AND UPDATES ON THE ABVS AND ISVS
| The Saga Of The ABVS: Farenheit 32 |
Stanley, James C. (M.D.) |
| How Can The APDVS Help Vascular Surgery Gain Independent Governance: Why It Is So Important |
Keagy, Blair A. (M.D.) |
| How The SVS Can Help Vascular Surgery Gain Independence: Why Is It So Important |
Ascher, Enrico (M.D.) |
| Reaction Of Interventional Cardiology To An ABMS Approved Vascular Board |
Rosenfield, Kenneth (M.D.) |
| The Legal Penalty Vascular Surgeons Must Face For Not Having An Independent Board |
Brown, O. William (M.D., J.D.) |
| Why There Should Be An Independent ABVS In North America: An Objective Outsider’s View: How The ISVS Can Help |
Bell, Peter R.F. (M.D., F.R.C.S., D.S.C., K.B.E.) |
| Progress Made By The ISVS Committee On Interventional Standards Of Practice And Training |
Gilling-Smith, Geoffrey L. (M.S., F.R.C.S.) |
| Panel Discussion |
|
Session XXV: PHILOSOPHICAL AND JUDGMENT ISSUES AND UPDATES
| Are Regulatory And Reimbursement Guidelines For Carotid Stenting (CAS) |
Abel, Dorothy B. (B.S.B.M.E.) |
| Safety And Effectiveness Of Multiple Reoperations After Two Or More Failed Lower Extremity Bypasses |
Lipsitz, Evan C. (M.D.) |
| Infection After Reoperative Lower Extremity Bypass Procedures: When Are The Best And Worse Times To Reoperate? |
Calligaro, Keith D. (M.D.) |
| Is Stenting Going To Put Open Vascular Surgery Out Of Business: In The Neck Or Elsewhere? |
Burnand, Kevin G. (M.B.B.S., F.R.C.S., M.S.) |
| Neck Trauma During Operation Iraqi Freedom: The Acute And Subacute Role Of The Vascular Surgeon |
Gillespie, David L. (M.D.) |
| A Forward Surgical Experience With The Marines In Iraq |
McCartney, Stephen F. (M.D., F.A.C.S.) |
| Panel Discussion |
|
Session XXVI: NEW DEVELOPMENTS IN THE PREVENTION AND TREATMENT OF COMPLICATIONS
| Intravascular Coil Embolization Can Cure Most Type II Endoleaks And Some Type I Endoleaks: How To Do It |
Makaroun, Michel S. (M.D.) |
| How To Avoid Early, Midterm And Late Complications With AneuRx Endografts In EVAR |
Sanchez, Luis A. (M.D.) |
| Debate: Branch Endograft To Revascularize Hypogastric Arteries During EVAR With Iliac Aneurysms: How Well Does It Work? |
Greenberg, Roy K. (M.D.) |
| Debate: Hypogastric Interruption During EVAR Is Relatively Safe With Iliac Aneurysms: When Is It Not And When Should Revascularization Be Attempted? |
Mehta, Manish (M.D., M.P.H.) |
| Ischemic Complications Of EVAR And How To Prevent And Treat Them |
Adelman, Mark A. (M.D.) |
| Factors Contributing To True And Apparent Graft Migration After EVAR With The Powerlink Endogaft: The Importance Of AAA Sac Remodeling |
White, Rodney A. (M.D.) |
| What’s New In Finite Element Analysis And Other Indirect Methods For Predicting AAA Rupture Risk |
Fillinger, Mark F. (M.D.) |
| Panel Discussion |
|
Session XXVII: NEW TECHNIQUES AND CONCEPTS
| Technique For Balloon Control Of The Aorta During EVAR For Ruptured AAA |
Malina, Martin (M.D., Ph.D.) |
| The RENU Device: A New System For Endovascular Rescue Of Stent Grafts That Have Migrated Or Failed In Other Ways |
Money, Samuel R. (M.D., M.B.A.) |
| Use Of Prostagladin E1 To Treat Trash Foot After Aortic Surgery |
Parodi, Juan C. (M.D.) |
| Open Surgical Care Of Children <12 With Vascular Injuries: Problems And Precautions |
Dalsing, Michael C. (M.D.) |
| Dynamic MRA Of The Necks Of Infrarenal AAAs: Pulsatility, Sizing And The Influence Of Endograft Treatment |
Verhagen, Hence J.M. (M.D., Ph.D.) |
| Brachial To Distal Hand Artery Bypasses For Finger Gangrene: A New Horizon For Vascular Surgeons And How To Perform Them |
Chang, Benjamin B. (M.D.) |
| Infrarenal Aortic Length Does Not Change With Sac Shrinkage After EVAR |
Beebe, Hugh G. (M.D.) |
| Panel Discussion |
|
| Why Lower Extremity Amputation Rates Are Higher In Black Patients: What Can Be Done To Improve Results? |
Mendes, Donna M. (M.D., F.A.C.S.) |
| Gold Coverings Improve Stent Visibility But Increase Restenosis |
Powell, Richard J. (M.D.) |
| Iliac Fixation Is The Key To Preventing Stent-Graft Migration After EVAR |
Zarins, Christopher K. (M.D.) |
| Aorfix Flexible Endograft For EVAR: What Can It Do That Other Grafts Cannot Based On 3-Year Clinical Results? |
Hopkinson, Brian R. (Ch.M., F.R.C.S.) |
| Mid-term Results With The Cordis-Fortron Stent-Graft System For EVAR: Phase I Study Update |
Brener, Bruce J. (M.D.) |
| Unintended Consequences Of Subtle Changes In Stent-Graft Design And Resulting Changes In Hemodynamic Forces: Clinical Significance |
Chuter, Timothy A.M. (M.D.) |
| Panel Discussion |
|
| A New Physiologic Assessment Scale To Allow Risk Stratification Of Ruptured Aortic Aneurysm Patients |
Moore, Randy D. (M.D.) |
| Proximal Neck Dilatation Does Not Occur After EVAR With A Balloon Expandable Endograft |
Malas, Mahmoud B. (M.D.) |
| What The Vascular Surgeon Needs To Know About Ehlers-Danlos Syndrome Based On The Mayo Clinic Experience |
Panneton, Jean M. (M.D.) |
| Panel Discussion |
|
| Holistic Approach To Type B Dissections: A Unique New Method |
Mossop, Peter J. (M.D.) |
| Introducing AAAdvantage: The Next Generation AneuRx Stent Graft |
Ramaiah, Venkatesh G. (M.D.) |
| Use Of Talent Thoracic Stent Graft For Aortic Dissection |
White, Rodney A. (M.D.) |
Session XXVIII: UPDATES AND RECENT ADVANCES
Are There Differences In Expected And Actual Results With Carotid Endarterectomy (CEA)?
|
Perler, Bruce A. (M.D., M.B.A.) |
Flow Reversal For CAS And Treatment Of Strokes: Advantages And Limitations
|
Parodi, Juan C. (M.D.) |
| Limits Of Zenith Endograft For EVAR And How Can They Be Extended |
Lipsitz, Evan C. (M.D.) |
| Device Specific Outcomes In EVAR: Does The Graft Make A Difference? |
Ouriel, Kenneth (M.D., F.A.C.S., F.A.C.C.) |
| Post EVAR Rupture Rate Can Be As Low As 0.5%: Is It The Result Of Treating More Small AAAs? Maybe They Need No Treatment At All |
Raithel, Dieter (M.D., Ph.D.) |
| Aortic Reconstructive Surgery In Children: Indications, Techniques And Precautions |
Stanley, James C. (M.D.) |
| Video Assisted First Rib Resection: Is It Easier Or Better? |
Martinez, Bernardo D. (M.D.) |
| Panel Discussion |
|
| Current Concepts Regarding The Etiology And Prevention Of Paraplegia After Thoracic Stent Grafting |
Hollier, Larry H. (M.D.) |
| Thoracic Aortic Perforation By Endograft Stent Struts: Is It A Design Flaw Or An Inherent Risk Of The Procedure? |
White, Geoffrey H. (M.D.) |
| Mechanism Of Component Separation Of Modular Thoracic Endografts: How Can This Be Prevented? |
Lawrence-Brown, Michael (M.D., F.R.A.C.S.) |
| Results Of Medtronic-Talent Thoracic Stent-Graft Trial: Who Can’t Have Stent-Graft Treatment And Why? |
Fairman, Ronald M. (M.D.) |
| Prospective Randomized Comparison Of Acuseal (Goretex) Versus Hemashield-Finesse Patching During CEA: Which Is Better? |
AbuRahma, Ali F. (M.D.) |
| Dilatation Of Aortic Grafts: Is It A Clinically Important Problem? |
Schroeder, Torben V. (M.D., D.M.Sc.) |
| Are Fenestrated Grafts Really Necessary: What Is A Short Infrarenal Neck And How Does It Affect The Results Of EVAR? |
Buth, Jacob (M.D.) |
| Panel Discussion |
|
Session XXIX: NEW DEVELOPMENTS IN THE MANAGEMENT OF CAROTID, VERTEBRAL AND SUPRA-AORTIC TRUNK DISEASE
| Gender Differences In Carotid Stenosis: Are We Over-Diagnosing Carotid Disease In Women? |
Comerota, Anthony J. (M.D.) |
| Covered Stents To Manage Difficult Carotid Artery Lesions: Techniques, Indications And Pitfalls |
Schonholz, Claudio (M.D.) |
| Indications And Techniques For Carotid - Carotid Bypass |
Sullivan, Timothy M. (M.D.) |
| SAPPHIRE Eligible High Risk Patients Can Be Well Treated With CEA: So Where Is The Beef? |
Berguer, Ramon (M.D., Ph.D.) |
| Reoperative Carotid Endarterectomy: Are The Risks Really So High That CAS Should Be The Primary Treatment: When Should It Be? |
Cambria, Richard P. (M.D.) |
| 10 Top Tips For Subclavian And Vertebral Revascularization |
Amor, Max (M.D.) |
| Panel Discussion |
|
| Debate: Late Results With Eversion CEA: Technical Details That Make It A Better Way |
Darling III, R. Clement (M.D.) |
| Eversion CEA Is Not All It Is Cracked Up To Be: It Should Not Be Widely Adopted |
Brothers, Thomas E. (M.D.) |
| Improved Outcomes Of CEA: Does It Matter If A Vascular Surgeon Does The Operation? |
Dardik, Alan (M.D., Ph.D.) |
| Is It Useful To Identify High Risk Carotid Plaques Before Surgery/Stenting: How Is It Best Done And What To Do About Them |
Liapis, Christos D. (M.D.) |
| Risk Factors For Perioperative Stroke After CEA: Hypercoagulability Is Key |
LaMuraglia, Glenn M. (M.D.) |
| Panel Discussion |
|
Session XXX: NEW DEVELOPMENTS IN STENTING OF THE CAROTID BIFURCATION AND SUPRA-AORTIC TRUNKS
| CEA Should Be The Treatment Of Choice For Most Forms Of Carotid Bifurcation Disease: Are There New Adjuncts That Help? |
Buckley, Clifford J. (M.D.) |
| Overview Of All Randomized Trials Of CEA Versus CAS |
Naylor, A. Ross (M.D., F.R.C.S.) |
| Early And Late Results Of CAS In The Italian Registry: What Are The Limits Of Registry Data? |
Biasi, Giorgio M. (M.D.) |
| 10 Top Technical Tips For CAS And Avoiding Complications |
Silva, Jr., Michael B. (M.D.) |
| My 10 Top Technical Tips For Safe CAS |
Schneider, Peter A. (M.D.) |
| Carotid Hemodynamics After CAS: Are There Gender Differences? |
Timaran, Carlos H. (M.D.) |
| Are Brain Protection Devices All They Are Cracked Up To Be? |
van den Berg, Jos C. (M.D., Ph.D.) |
| Panel Discussion |
|
Session XXXI: LATE BREAKING NEW ADVANCES AND ISSUES
| How To Guide Stent-Graft Implantation In Type B Aortic Dissections: Comparison Of Angiography, TEE And IVUS |
Koschyk, Dietmar H. (M.D.) |
| Comparison Of Results Of Endovascular Procedures Performed By Different Specialists: Vascular Surgeons Do As Well As Other Interventionalists |
Passman, Marc A. (M.D.) |
| Will Certificates Of Added Qualifications (CAQs) In Vascular Surgery Be A Good Thing? |
Berguer, Ramon (M.D., Ph.D.) |
| The Availability Of EVAR Reduces Overall Mortality Rates For Treating AAAs |
Polterauer, Peter (M.D.) |
| Percutaneous Isolated Limb Perfusion For Severe Ischemia In Patients Who Are Not Candidates For Standard Revascularization |
Eidt, John F. (M.D.) |
| Early Results Of The European SFA Treatment Registry: What Method Of Treatment Appears Best? |
Hoffmann, Gerhard (M.D.) |
| Simplified Approach To Severe Lymphedema: What Every Vascular Surgeon Should Know |
Lee, Byung-Boong (M.D.) |
| Simplified Approach To Congenital Vascular Malformations: What Every Vascular Surgeon Should Know |
Villavicencio, J. Leonel (M.D.) |
| A Biologically Active Stent Graft For Aortic Aneurysms: Rationale And Preclinical Data |
Machan, Lindsay S. (M.D.) |
| CAPTURE Post Market Study Results For The Accunet Embolic Protection Device And Acculink Stent: 30-Day Stroke, Mortality And MI Rates |
Green, Richard M. (M.D.) |
| Hemodynamics In AV Access: The Advantage Of The Venaflo® Graft |
Haag, Brian W. (MD, FACS) |
| Panel Discussion |
|
-Return
to Product Page-
Screen Shots
Back To Top
Back To Top
Back To Top
Back To Top
Back To Top
Back To Top
|
